
Fortrea Holdings Inc. — Investor Relations & Filings
Fortrea Holdings Inc. is a global contract research organization (CRO) that provides clinical development and patient access solutions to the life sciences industry. The company offers comprehensive services for biopharmaceutical and medical technology clients, including the management of Phase I through IV clinical trials, clinical pharmacology, and market access support. Fortrea focuses on accelerating the delivery of new therapies by utilizing data, technology, and flexible, patient-centric approaches. The organization also engages in strategic collaborations to provide end-to-end solutions in specialized areas such as cell and gene therapy development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Fortrea Holdings Inc. (0001965040) (Filer) | 2026-05-05 | English | |
| ARS - Fortrea Holdings Inc. (0001965040) (Filer) | 2026-04-27 | English | |
| DEF 14A - Fortrea Holdings Inc. (0001965040) (Filer) | 2026-04-27 | English | |
| 4 - Fortrea Holdings Inc. (0001965040) (Issuer) | 2026-03-24 | English | |
| 10-K - FORTREA HOLDINGS INC. (0001965040) (Filer) | 2026-02-26 | English | |
| 8-K - FORTREA HOLDINGS INC. (0001965040) (Filer) | 2026-02-26 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 41327050 | 8-K - Fortrea Holdings Inc. (0001965040) (Filer) | 2026-05-05 | English | ||
| 37394383 | ARS - Fortrea Holdings Inc. (0001965040) (Filer) | 2026-04-27 | English | ||
| 37392257 | DEF 14A - Fortrea Holdings Inc. (0001965040) (Filer) | 2026-04-27 | English | ||
| 33034991 | 4 - Fortrea Holdings Inc. (0001965040) (Issuer) | 2026-03-24 | English | ||
| 32900746 | 10-K - FORTREA HOLDINGS INC. (0001965040) (Filer) | 2026-02-26 | English | ||
| 32900745 | 8-K - FORTREA HOLDINGS INC. (0001965040) (Filer) | 2026-02-26 | English | ||
| 32259303 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32259264 | 4 Filing | 2026-02-11 | English | ||
| 32259220 | 4 Filing | 2026-02-11 | English | ||
| 13643234 | Regulatory Filings 2026 | 2026-01-20 | English | ||
|
2025
5 filings
| |||||
| 13643235 | PRIMARY DOCUMENT | 2025-11-24 | English | ||
| 13643236 | 8-K | 2025-11-20 | English | ||
| 13643237 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13643238 | 10-Q | 2025-11-05 | English | ||
| 13643239 | 8-K | 2025-11-05 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
Fortrea Holdings Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32445/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32445 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32445 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32445 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32445}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fortrea Holdings Inc. (id: 32445)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.